This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Memorial Sloan Kettering Cancer Center, Takeda Pharmaceutical Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 621 
1 out of 1,226 
Years Active: 2026
Title: Adrian Schwartz-Mittleman: Innovator in Antibody Research
Introduction
Adrian Schwartz-Mittleman is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-based therapies. His work has the potential to impact various medical applications, especially in cancer treatment.
Latest Patents
Adrian holds a patent for "CCR8 Antibodies, Antibody Conjugates, and Uses Thereof." This patent represents a crucial advancement in the understanding and application of antibodies in therapeutic settings. With 1 patent to his name, his innovative approach is paving the way for new treatment options.
Career Highlights
Throughout his career, Adrian has worked with prestigious organizations such as Memorial Sloan Kettering Cancer Center and Takeda Pharmaceutical Company Limited. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Adrian has collaborated with talented individuals, including Cierra Casson and Sarah Hesse. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Adrian Schwartz-Mittleman is a prominent figure in the realm of antibody research, with a focus on developing novel therapeutic solutions. His contributions and collaborations highlight the importance of innovation in the fight against diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile